Markets

Cortland Associates Inc Buys Cognizant Technology Solutions Corp, Centene Corp, The Advisory ...

Cortland Associates Inc

  • New Purchases: PGR , CELG ,
  • Added Positions: CTSH , ESRX, CNC, ABCO, IVV, AAPL,
  • Reduced Positions:PRGO, BABA, BIDU, CVS, BLBD, IDXX, ECYT, JNJ, PG,
  • Sold Out:FTV,

For the details of CORTLAND ASSOCIATES INC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=CORTLAND+ASSOCIATES+INC

These are the top 5 holdings of CORTLAND ASSOCIATES INC

  1. Express Scripts Holding Co ( ESRX ) - 870,584 shares, 12.26% of the total portfolio. Shares added by 13.58%
  2. Cognizant Technology Solutions Corp ( CTSH ) - 976,608 shares, 11.2% of the total portfolio. Shares added by 26.59%
  3. Visa Inc ( V ) - 618,519 shares, 9.88% of the total portfolio. Shares reduced by 0.02%
  4. CVS Health Corp ( CVS ) - 537,274 shares, 8.68% of the total portfolio. Shares reduced by 1.06%
  5. Alphabet Inc ( GOOGL ) - 46,430 shares, 7.53% of the total portfolio. Shares added by 0.55%

New Purchase: Progressive Corp (PGR)

Cortland Associates Inc initiated holdings in Progressive Corp. The purchase prices were between $30.88 and $35.74, with an estimated average price of $33.07. The stock is now traded at around $38.00. The impact to the portfolio due to this purchase was 0.05%. The holdings were 6,196 shares as of 2016-12-31.

New Purchase: Celgene Corp (CELG)

Cortland Associates Inc initiated holdings in Celgene Corp. The purchase prices were between $97.63 and $124.16, with an estimated average price of $111.36. The stock is now traded at around $113.76. The impact to the portfolio due to this purchase was 0.04%. The holdings were 1,790 shares as of 2016-12-31.

Added: Cognizant Technology Solutions Corp ( CTSH )

Cortland Associates Inc added to the holdings in Cognizant Technology Solutions Corp by 26.59%. The purchase prices were between $49.71 and $57.1, with an estimated average price of $53.52. The stock is now traded at around $56.09. The impact to the portfolio due to this purchase was 2.35%. The holdings were 976,608 shares as of 2016-12-31.

Added: Centene Corp (CNC)

Cortland Associates Inc added to the holdings in Centene Corp by 29.11%. The purchase prices were between $50.68 and $66.8, with an estimated average price of $59.01. The stock is now traded at around $63.84. The impact to the portfolio due to this purchase was 1.24%. The holdings were 473,362 shares as of 2016-12-31.

Added: The Advisory Board Co (ABCO)

Cortland Associates Inc added to the holdings in The Advisory Board Co by 108.10%. The purchase prices were between $31.95 and $43.76, with an estimated average price of $36.96. The stock is now traded at around $44.98. The impact to the portfolio due to this purchase was 0.96%. The holdings were 271,429 shares as of 2016-12-31.

Added: iShares Core S&P 500 (IVV)

Cortland Associates Inc added to the holdings in iShares Core S&P 500 by 22.77%. The purchase prices were between $209.67 and $229.05, with an estimated average price of $219.92. The stock is now traded at around $230.40. The impact to the portfolio due to this purchase was 0.04%. The holdings were 4,335 shares as of 2016-12-31.

Sold Out: Fortive Corp (FTV)

Cortland Associates Inc sold out the holdings in Fortive Corp. The sale prices were between $47.49 and $55.97, with an estimated average price of $52.45.

Reduced: Perrigo Co PLC (PRGO)

Cortland Associates Inc reduced to the holdings in Perrigo Co PLC by 20.4%. The sale prices were between $79.95 and $96.73, with an estimated average price of $86.74. The stock is now traded at around $73.90. The impact to the portfolio due to this sale was -0.6%. Cortland Associates Inc still held 123,483 shares as of 2016-12-31.

Reduced: Blue Bird Corp (BLBD)

Cortland Associates Inc reduced to the holdings in Blue Bird Corp by 26.04%. The sale prices were between $14.1 and $17.35, with an estimated average price of $15.57. The stock is now traded at around $16.95. The impact to the portfolio due to this sale was -0.03%. Cortland Associates Inc still held 30,549 shares as of 2016-12-31.

Reduced: Endocyte Inc (ECYT)

Cortland Associates Inc reduced to the holdings in Endocyte Inc by 33.33%. The sale prices were between $2.55 and $3.39, with an estimated average price of $2.87. The stock is now traded at around $2.23. The impact to the portfolio due to this sale was less than 0.01%. Cortland Associates Inc still held 10,000 shares as of 2016-12-31.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CTSH GOOGL V CVS

Other Topics

Stocks

Latest Markets Videos